Biofrontera Selling General Administrative from 2010 to 2024

BFRIW Stock  USD 0.09  0.01  12.22%   
Biofrontera Warrants Selling General Administrative yearly trend continues to be fairly stable with very little volatility. Selling General Administrative will likely drop to about 35 M in 2024. During the period from 2010 to 2024, Biofrontera Warrants Selling General Administrative regression line of quarterly data had mean square error of 21.4 T and geometric mean of  29,729,771. View All Fundamentals
 
Selling General Administrative  
First Reported
2010-12-31
Previous Quarter
39.1 M
Current Value
35 M
Quarterly Volatility
M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Biofrontera Warrants financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biofrontera Warrants' main balance sheet or income statement drivers, such as Tax Provision of 33 K, Interest Income of 90.6 K or Depreciation And Amortization of 1.5 M, as well as many indicators such as Price To Sales Ratio of 0.12, Dividend Yield of 0.0 or PTB Ratio of 0.85. Biofrontera financial statements analysis is a perfect complement when working with Biofrontera Warrants Valuation or Volatility modules.
  
Check out the analysis of Biofrontera Warrants Correlation against competitors.
For more information on how to buy Biofrontera Stock please use our How to Invest in Biofrontera Warrants guide.

Latest Biofrontera Warrants' Selling General Administrative Growth Pattern

Below is the plot of the Selling General Administrative of Biofrontera Warrants over the last few years. It is Biofrontera Warrants' Selling General Administrative historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biofrontera Warrants' overall financial position and show how it may be relating to other accounts over time.
Selling General Administrative10 Years Trend
Slightly volatile
   Selling General Administrative   
       Timeline  

Biofrontera Selling General Administrative Regression Statistics

Arithmetic Mean30,150,464
Geometric Mean29,729,771
Coefficient Of Variation16.64
Mean Deviation3,545,081
Median28,695,000
Standard Deviation5,017,576
Sample Variance25.2T
Range21M
R-Value0.46
Mean Square Error21.4T
R-Squared0.21
Significance0.08
Slope517,185
Total Sum of Squares352.5T

Biofrontera Selling General Administrative History

202435 M
202339.1 M
202235.9 M
202137.2 M
202018.1 M

About Biofrontera Warrants Financial Statements

Biofrontera Warrants investors use historical fundamental indicators, such as Biofrontera Warrants' Selling General Administrative, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biofrontera Warrants. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Selling General Administrative39.1 M35 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biofrontera Stock Analysis

When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.